default author photo

Takayuki Kanno

National Institute of Infectious Diseases

1-23-1 Toyama Shinjuku Yokyo

Japan

SCHOLARLY PAPERS

2

DOWNLOADS

70

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Reduced Resistance of SARS-CoV-2 Variants Toward Affinity-Matured Serological Immunity

Number of pages: 58 Posted: 21 Apr 2021
Saya Moriayma, Yu Adachi, Takashi Sato, Keisuke Tonouchi, Lin Sun, Shuetsu Fukushi, Souichi Yamada, Hitomi Kinoshita, Kiyoko Nojima, Takayuki Kanno, Minoru Tobiume, Keita Ishijima, Yudai Kuroda, Park Eunsil, Taishi Onodera, Takayuki Matsumura, Tomohiro Takano, Kazutaka Terahara, Masanori Isogawa, Ayae Nishiyama, Ai Kawana-Tachikawa, Masaharu Shinkai, Natsuo Tachikawa, Shigeki Nakamura, Takahiro Okai, Kazu Okuma, Tetsuro Matano, Tsuguto Fujimoto, Ken Maeda, Makoto Ohnishi, Takaji Wakita, Tadaki Suzuki and Yoshimasa Takahashi
National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development, Tokyo Shinagawa Hospital, National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases - Department of Immunology, National Institute of Infectious Diseases - Department of Virology I, National Institute of Infectious Diseases, National Institute of Infectious Diseases, National Institute of Infectious Diseases, National Institute of Infectious Diseases, National Institute of Infectious Diseases, National Institute of Infectious Diseases, National Institute of Infectious Diseases, National Institute of Infectious Diseases - Department of Veterinary Science, National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases - AIDS Research Center, Tokyo Shinagawa Hospital, Yokohama Municipal Citizen's Hospital - Division of Infectious Disease, Tokyo Medical University, affiliation not provided to SSRN, National Institute of Infectious Diseases, National Institute of Infectious Diseases - AIDS Research Center, National Institute of Infectious Diseases, National Institute of Infectious Diseases - Department of Veterinary Science, National Institute of Infectious Diseases - Department of Bacteriology I, National Institute of Infectious Diseases - Department of Virology II, National Institute of Infectious Diseases - Department of Pathology and National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development
Downloads 43 (1,145,425)

Abstract:

Loading...

2.

Intranasal Vaccination Induced Cross-Protective Secretory IgA Antibodies Against SARS-CoV-2 Variants with Reducing the Potential Risk of Lung Eosinophilic Immunopathology

Number of pages: 48 Posted: 16 Jun 2022
Takuya Hemmi, Akira Ainai, Takao Hashiguchi, Minoru Tobiume, Takayuki Kanno, Naoko Iwata, Shun Iida, Yuko Sato, Sho Miyamoto, Akira Ueno, Kaori Sano, Shinji Saito, Nozomi Shiwa, Noriyo Nagata, Koji Tamura, Ryosuke Suzuki, Hideki Hasegawa and Tadaki Suzuki
National Institute of Infectious Diseases - Department of Pathology, National Institute of Infectious Diseases - Department of Pathology, Kyoto University, National Institute of Infectious Diseases, National Institute of Infectious Diseases, National Institute of Infectious Diseases - Department of Pathology, National Institute of Infectious Diseases, National Institute of Infectious Diseases, National Institute of Infectious Diseases, National Institute of Infectious Diseases, National Institute of Infectious Diseases, National Institute of Infectious Diseases, National Institute of Infectious Diseases - Department of Pathology, National Institute of Infectious Diseases - Department of Pathology, Tokyo University of Science - Department of Biological Science and Technology, National Institute of Infectious Diseases - Department of Virology II, National Institute of Infectious Diseases and National Institute of Infectious Diseases
Downloads 27 (1,359,097)

Abstract:

Loading...

intranasal vaccination, secretory IgA antibody, COVID-19, SARS-CoV-2, lung eosinophilic immunopathology